Table 1 Comparison of general data between the two groups.

From: Comparative efficacy and safety of pulsed radiofrequency versus spinal cord stimulation in thoracic herpes zoster pain: a retrospective study

Variables

 

Experimental group (SCS)

Control group (PRF)

Statistical value

P-value

Gender

Male

58(45.67%)

71(47.97%)

0.068

0.795

 

Female

69(54.33%)

77(52.03%)

  

Age

 

68.57 ± 8.99

65.91 ± 11.84

–2.12

0.035

Disease duration

Acute Phase

32(25.20%)

67(45.27%)

13.13

0.001

 

Subacute Phase

57(44.88%)

55(37.16%)

  
 

Sequelae Phase

38(29.92%)

26(17.57%)

  

Side

Left

65(51.18%)

68(45.95%)

0.75

0.386

 

Right

62(48.81%)

80(54.05%)

  

VAS score

 

6.78 ± 0.77

6.62 ± 0.74

0.091

0.083

PQSI

 

15.79 ± 1.48

15.73 ± 1.39

0.17

0.739

BPI

 

34.61 ± 3.04

34.14 ± 3.44

0.39

0.232

HADS-A Score

 

12.27 ± 0.18

12.11 ± 0.16

0.24

0.488

HADS-D Score

 

12.87 ± 1.72

12.71 ± 1.50

0.19

0.420

Complication

Yes

1(0.79%)

1(0.68%)

0.012

0.913

 

No

126(99.21%)

147(99.32%)